Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Tags & Cell Markers >> Cell Type Markers >> Tumor Associated
Anti-Cytokeratin 18 antibody [C-04]
See all Cytokeratin 18 products (35) ...
Mouse monoclonal [C-04] to Cytokeratin 18
Human Cytokeratin
ICC, IHC-P, WB, Flow Cyt, IHC-Fr, IP, ICC/IFmore details
Reacts with
Mouse, Rat, Sheep, Goat, Horse, Hamster, Cow, Dog, Human, Pig
Tissue / cell preparation (Human). (Cytoskeleton preparation of epidermal carcinoma cell line A431).
A431 cells
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 15mM Sodium Azide
Constituents: PBS, pH 7.4
Concentration information loading...
>95% by SDS-PAGE
Purified from culture supernatant using protein A-affinity chromatography.
Monoclonal
C-04
IgG1
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Intermediate Filaments >> Class I >> Cytokeratins
Tags & Cell Markers >> Cell Type Markers >> Tumor Associated
Our Abpromise guarantee covers the use of ab668 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC: Use at an assay dependent dilution.
IHC-P: Use at an assay dependent dilution. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
WB: Use at an assay dependent dilution. Predicted molecular weight: 45 kDa.
Flow Cyt: Use 1µg for 106 cells. ((also see PMID 18946470))
IHC-Fr: Use at an assay dependent dilution.
IP: Use at an assay dependent dilution.
ICC/IF: Use at an assay dependent dilution.
Involved in the uptake of thrombin-antithrombin complexes by hepatic cells (By similarity). When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection.
Expressed in colon, placenta, liver and very weakly in exocervix. Increased expression observed in lymph nodes of breast carcinoma.
Defects in KRT18 are a cause of cirrhosis (CIRRH) [MIM:215600].
Belongs to the intermediate filament family.
Phosphorylation at Ser-34 increases during mitosis. Hyperphosphorylated at Ser-53 in diseased cirrhosis liver. Phosphorylation increases by IL-6.
Proteolytically cleaved by caspases during epithelial cell apoptosis. Cleavage occurs at Asp-238 by either caspase-3, caspase-6 or caspase-7.
O-glycosylated at multiple sites; glycans consist of single N-acetylglucosamine residues.
Cytoplasm > perinuclear region.
Target information above from: UniProt accessionP05783
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Flow Cytometry - Anti-Cytokeratin 18 antibody [C-04] (ab668)
![Flow Cytometry - Anti-Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-11.jpg)
Overlay histogram showing HCT116 cells stained with ab668 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100® for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab668, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HCT116 cells fixed with 4% paraformaldehyde/permeabilized in 0.1% PBS-Triton® used under the same conditions.
Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/Images/0/ab668/ab668_2.jpg)
ab668 at 1/100 staining A431 Human epithelial carcinoma cells by ICC/IF. The cells were paraformaldehyde fixed, permeabilized with 0.25% Triton X-100 and then blocked with BSA prior to incubation with the antibody for 24 hours at 4°C. A FITC conjugated goat anti-mouse IgG antibody was used as the secondary. The right hand image shows staining with ab668 followed by secondary antibody. The left hand image shows DAPI staining with secondary only.
This image is courtesy of an anonymous Abreview
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 18 antibody [C-04] (ab668)
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-1.jpg)
ab668 (2µg/ml) staining cytokeratin 18 in human skin using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining of sweat coils.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-7.jpg)
ab668 staining Cytokeratin 18 in horse primary bronchial epithelial cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in acetone and then blocked using 3% BSA for 10 hours at 4°C. Samples were then incubated with primary antibody at 1/100 for 1 hour at 22°C. The secondary antibody used was a goat anti-mouse conjugated to FITC used at a 1/200 dilution.
Image courtesy of an anonymous Abreview.
This product has been referenced in:
See all 12 publications for this product
Publishing research using ab668? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Flow Cytometry - Anti-Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-11.jpg)
Overlay histogram showing HCT116 cells stained with ab668 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100® for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab668, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/Images/0/ab668/ab668_2.jpg)
ab668 at 1/100 staining A431 Human epithelial carcinoma cells by ICC/IF. The cells were paraformaldehyde fixed, permeabilized with 0.25% Triton X-100 and then blocked with BSA prior to incubation with the antibody for 24 hours at 4°C. A FITC conjugated goat anti-mouse IgG antibody was used as the secondary. The right hand image shows staining with ab668 followed by secondary antibody. The left hand image shows DAPI staining with secondary only.
This image is courtesy of an anonymous Abreview
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-1.jpg)
ab668 (2µg/ml) staining cytokeratin 18 in human skin using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining of sweat coils.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
![Immunocytochemistry/ Immunofluorescence - Cytokeratin 18 antibody [C-04] (ab668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-7.jpg)
ab668 staining Cytokeratin 18 in horse primary bronchial epithelial cells by Immunocytochemistry/ Immunofluorescence. The cells were fixed in acetone and then blocked using 3% BSA for 10 hours at 4°C. Samples were then incubated with primary antibody at 1/100 for 1 hour at 22°C. The secondary antibody used was a goat anti-mouse conjugated to FITC used at a 1/200 dilution.
Image courtesy of an anonymous Abreview.
![Cytokeratin 18 antibody [C-04] for Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) in Goat (668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-9.jpg)
![Cytokeratin 18 antibody [C-04] for Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) in Sheep (668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-10.jpg)
![Cytokeratin 18 antibody [C-04] for Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) in Cow (668)](/ps/datasheet/images/0/ab668/Cytokeratin-18-Primary-antibodies-ab668-8.jpg)
7
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
